Amylyx Pharmaceuticals (AMLX) Non Operating Income (2021 - 2026)
Amylyx Pharmaceuticals' Non Operating Income came in at $2.27 million for Q2 2026, up 60.5% from $1.41 million a year earlier but down 9.0% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Non Operating Income (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Amylyx Pharmaceuticals reported Non Operating Income of $10.06 million, up 15.1% year-over-year; for FY2025, it was $8.6 million, down 31.7% from FY2024.
- Going back by year, Non Operating Income was $12.6 million in FY2024 (-18.7%), $15.5 million in FY2023 (+314.3%), $3.74 million in FY2022 and -$5.24 million in FY2021.
- The five-year range for quarterly Non Operating Income is -$224,000 (Q3 2021) to $4.54 million (Q4 2023).
- Year-over-year, Non Operating Income has increased for three consecutive quarters, with an average decline of 9.7% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q2 2023 (growth of 957.2%), and the weakest in Q2 2025 (a decline of 60.6%).
- Business Quant data shows AMLX's Non Operating Income at $2.5 million (Q1 2026), $3.65 million (Q4 2025) and $1.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Amylyx Pharmaceuticals | 3.24 Bn | 3.24 Bn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.96 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 3.81 Mn |
| Mar 31, 2023 | 3.46 Mn |
| Dec 31, 2022 | 2.47 Mn |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 360,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | -29,000.00 |
| Sep 30, 2021 | -224,000.00 |
API Access
Amylyx Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();